The company's stock was trading down 56 cents at 40

The company estimates the total cost for the two generatingunits to be about $14 billion and expects them to beoperational in the 2016 to 2018 time frame. An additional $3 billion is estimated for the transmissionequipment and about 200 miles of transmission lines associatedwith the project. The majority of the project's costs will be invested by thecompany and its shareholders and will not be recovered fromcustomers through rates until the plant goes in service. However, starting this month customers will begin payingfor a portion of the costs of the project as approved by thePublic Service Commission, the company said. The company's stock was trading down 56 cents at $40.09late Monday morning on the New York Stock Exchange. 5 /PRNewswire/ Theodosius Dobzhansky, the lategreat geneticist and evolutionary biologist, said it best: "Nothing in biologymakes sense except in the light of evolution."This year marks the 200th birthday of Charles Darwin (February 12, 1809) andthe 150th anniversary of the publication of the Origin of Species, which laidout the theory of evolution by means of natural selection in exquisite detail.Universities, academic centers, and other scientific organizations all overthe globe have a plethora of events planned to honor Darwin's contributionsand legacy.

Genetic Engineering and Biotechnology News (GEN) is taking part inthe celebration of Darwin as well."If it weren't for Charles Darwin and Alfred Russel Wallace, there wouldprobably be no biotechnology industry," says John Sterling, Editor in Chief ofGEN. This is particularly the case with genetics and molecular biology, twocornerstones of biotech research."In the January 1 issue, GEN published excerpts of an interview with SeanCarroll, Ph.D., professor of molecular biology and genetics and aninvestigator with the Howard Hughes Medical Institute at the University ofWisconsin Dr. Carroll's research has centered on the genes that controlanimal body patterns and play major roles in the evolution of animaldiversity. This field of study is known as evolutionary developmental biology,or "Evo Devo." The entire interview with Dr. Carroll can be heard as a podcastat addition to providing his insights on the significance of Charles Darwinand the impact and importance of Evo Devo on the foundation of evolutionarytheory, Dr.

Carroll also discusses how research advances taking place in EvoDevo can be translated into applied biotech applications.During each subsequent month throughout 2009, GEN will interview a leadingresearcher, philosopher, or theorist in evolutionary science, including manyexperts on Darwin. Their thoughts and insights will appear in the printversion of GEN and online as podcasts. Dozens of online links to articles,videos, podcasts, commentaries, and various events and conferences around theworld celebrating Charles Darwin will also be provided. We cordially invite you to our year-long Darwin party!For a copy of the January 1 issue of GEN, please call (914) 740-2122, oremail: Genetic Engineering and Biotechnology News (GEN) (), whichis published 21 times a year by Mary Ann Liebert, Inc., is the most widelyread biotechnology news magazine worldwide. It includes articles on DrugDiscovery, Bioprocessing, OMICS, Biobusiness, and Clinical Research andDiagnostics.Contact: John Sterling, Editor in Chief, Genetic Engineering and BiotechnologyNews (914) 740-2196, SOURCEGenetic Engineering and Biotechnology News (GEN)John Sterling, Editor in Chief, Genetic Engineering and Biotechnology News,1-914-740-2196, .